These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2692413)

  • 21. Kinin antagonist reverses converting enzyme inhibitor-stimulated vascular prostaglandin I2 synthesis.
    Beierwaltes WH; Carretero OA
    Hypertension; 1989 Jun; 13(6 Pt 2):754-8. PubMed ID: 2544521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
    Drapeau G; deBlois D; Marceau F
    J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible involvement of placental proteases in bradykinin (BK) degradation.
    Kuno N; Mizutani S; Ohno Y; Goto K; Itakura A; Kondo I; Kurauchi O; Kikkawa F; Tomoda Y
    Reprod Fertil Dev; 1997; 9(6):633-9. PubMed ID: 9551668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Potentiative effects of angiotensin converting enzyme inhibitors on carrageenan-induced edema in rats].
    Suda H; Yamauchi H; Iso T
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):517-23. PubMed ID: 6298082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of bradykinin generating and degrading systems in the vascular permeability response induced with kaolin in rats.
    Kumakura S; Tsurufuji S; Kurooka S; Sunahara N
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1067-73. PubMed ID: 3320343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of bradykinin-(1-5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generation.
    Majima M; Nishiyama K; Iguchi Y; Yao K; Ogino M; Ohno T; Sunahara N; Katoh K; Tatemichi N; Takei Y; Katori M
    Inflamm Res; 1996 Aug; 45(8):416-23. PubMed ID: 8872516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinin and enkephalin conversion by an endothelial, plasma membrane carboxypeptidase.
    Palmieri FE; Bausback HH; Churchill L; Ward PE
    Biochem Pharmacol; 1986 Aug; 35(16):2749-56. PubMed ID: 3091032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent inhibition of angiotensin-converting enzyme by [des-Pro3]-bradykinin or "converstatin" in comparison with Captopril.
    Okuda M; Arakawa K
    J Biochem; 1985 Sep; 98(3):621-8. PubMed ID: 3003038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
    Komori T; Takada T; Funae Y; Yamamoto K
    Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
    [No Abstract]   [Full Text] [Related]  

  • 31. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma.
    Shima C; Majima M; Katori M
    Jpn J Pharmacol; 1992 Oct; 60(2):111-9. PubMed ID: 1479739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide.
    Audet R; Rioux F; Drapeau G; Marceau F
    J Pharmacol Exp Ther; 1997 Jan; 280(1):6-15. PubMed ID: 8996175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood levels of kinins in experimental allergic encephalomyelitis.
    Germain L; Barabe J; Galeano C
    J Neuroimmunol; 1986 Dec; 13(2):135-42. PubMed ID: 3782464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of the digestion of bradykinin, lysyl bradykinin, and kinin-degradation products by carboxypeptidases A, B, and N.
    Sheikh IA; Kaplan AP
    Biochem Pharmacol; 1986 Jun; 35(12):1957-63. PubMed ID: 3718539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin.
    Martins DT; Fior DR; Nakaie CR; Lindsey CJ
    Br J Pharmacol; 1991 Aug; 103(4):1851-6. PubMed ID: 1655143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
    Blais C; Drapeau G; Raymond P; Lamontagne D; Gervais N; Venneman I; Adam A
    Am J Physiol; 1997 Nov; 273(5):H2263-71. PubMed ID: 9374762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of the pro-inflammatory effects of bradykinin by inhibition of angiotensin-converting enzyme and aminopeptidase P in rat paws.
    Damas J; Liégeois JF; Simmons WH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):670-6. PubMed ID: 8938668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion of T-kinin to bradykinin by the rat kidney.
    Vieira MA; Moreira MF; Maack T; Guimarães JA
    Biochem Pharmacol; 1994 Apr; 47(9):1693-9. PubMed ID: 8185685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the activation of the kallikrein-kinin system in experimental asbestosis.
    Barabé J; Sirois P; St-Pierre S
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):93-8. PubMed ID: 6145197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.